2015 Q2 Form 10-Q Financial Statement

#000156459015006142 Filed on August 05, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $23.72M $11.70M
YoY Change 102.83% -49.34%
Cost Of Revenue $20.50M $12.09M
YoY Change 69.63% -32.8%
Gross Profit $3.220M -$391.0K
YoY Change -923.53% -107.67%
Gross Profit Margin 13.57% -3.34%
Selling, General & Admin $7.535M $7.938M
YoY Change -5.08% -26.68%
% of Gross Profit 234.01%
Research & Development $3.162M $3.120M
YoY Change 1.35% 3.07%
% of Gross Profit 98.2%
Depreciation & Amortization $39.00K $2.475M
YoY Change -98.42% -6.78%
% of Gross Profit 1.21%
Operating Expenses $10.70M $11.06M
YoY Change -3.26% -65.37%
Operating Profit -$8.257M -$12.67M
YoY Change -34.81% 43.13%
Interest Expense $300.0K $500.0K
YoY Change -40.0% -76.19%
% of Operating Profit
Other Income/Expense, Net -$772.0K -$152.0K
YoY Change 407.89% -320.29%
Pretax Income -$8.547M -$13.39M
YoY Change -36.16% 28.46%
Income Tax $600.0K $128.0K
% Of Pretax Income
Net Earnings -$9.121M -$13.52M
YoY Change -32.52% 28.57%
Net Earnings / Revenue -38.45% -115.57%
Basic Earnings Per Share -$0.75 -$1.74
Diluted Earnings Per Share -$0.75 -$1.74
COMMON SHARES
Basic Shares Outstanding 12.11M shares 7.769M
Diluted Shares Outstanding 12.11M shares 7.769M

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.60M $36.60M
YoY Change 5.46% 12.27%
Cash & Equivalents $38.56M $36.62M
Short-Term Investments
Other Short-Term Assets $13.00M $14.60M
YoY Change -10.96% -40.89%
Inventory $17.10M $19.40M
Prepaid Expenses
Receivables $8.500M $10.30M
Other Receivables $0.00 $0.00
Total Short-Term Assets $77.10M $81.00M
YoY Change -4.81% -18.3%
LONG-TERM ASSETS
Property, Plant & Equipment $54.40M $62.50M
YoY Change -12.96% -13.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.10M $15.20M
YoY Change -33.55% 67.64%
Total Long-Term Assets $65.80M $79.60M
YoY Change -17.34% -16.26%
TOTAL ASSETS
Total Short-Term Assets $77.10M $81.00M
Total Long-Term Assets $65.80M $79.60M
Total Assets $142.9M $160.6M
YoY Change -11.02% -17.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.613M $2.554M
YoY Change 158.93% -38.81%
Accrued Expenses $11.50M $15.90M
YoY Change -27.67% -24.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.800M $5.900M
YoY Change -35.59% -49.57%
Total Short-Term Liabilities $41.90M $49.86M
YoY Change -15.96% -26.15%
LONG-TERM LIABILITIES
Long-Term Debt $2.900M $5.500M
YoY Change -47.27% -5.17%
Other Long-Term Liabilities $3.500M $1.023M
YoY Change 242.13% -12.19%
Total Long-Term Liabilities $6.400M $1.023M
YoY Change 525.61% -12.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $41.90M $49.86M
Total Long-Term Liabilities $6.400M $1.023M
Total Liabilities $48.30M $58.10M
YoY Change -16.86% -23.27%
SHAREHOLDERS EQUITY
Retained Earnings -$869.9M
YoY Change 7.31%
Common Stock $816.0K
YoY Change 33.77%
Preferred Stock
YoY Change
Treasury Stock (at cost) $739.0K
YoY Change 99.73%
Treasury Stock Shares
Shareholders Equity $94.60M $102.5M
YoY Change
Total Liabilities & Shareholders Equity $142.9M $160.6M
YoY Change -11.0% -17.32%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$9.121M -$13.52M
YoY Change -32.52% 28.57%
Depreciation, Depletion And Amortization $39.00K $2.475M
YoY Change -98.42% -6.78%
Cash From Operating Activities -$3.040M -$5.510M
YoY Change -44.83% -40.8%
INVESTING ACTIVITIES
Capital Expenditures $197.0K $287.0K
YoY Change -31.36% 195.88%
Acquisitions
YoY Change
Other Investing Activities -$130.0K $93.00K
YoY Change -239.78% -54.63%
Cash From Investing Activities -$60.00K -$270.0K
YoY Change -77.78% -107.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $22.30M
YoY Change
Debt Paid & Issued, Net $1.000M $1.442M
YoY Change -30.65% 24.96%
Cash From Financing Activities 21.18M -630.0K
YoY Change -3461.9% -47.98%
NET CHANGE
Cash From Operating Activities -3.040M -5.510M
Cash From Investing Activities -60.00K -270.0K
Cash From Financing Activities 21.18M -630.0K
Net Change In Cash 18.08M -6.410M
YoY Change -382.06% -4.95%
FREE CASH FLOW
Cash From Operating Activities -$3.040M -$5.510M
Capital Expenditures $197.0K $287.0K
Free Cash Flow -$3.237M -$5.797M
YoY Change -44.16% -38.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Inventory Net
InventoryNet
20596000
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10764000
CY2015Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2822000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20490000
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9879000
CY2015Q1 us-gaap Assets Current
AssetsCurrent
64551000
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56097000
CY2015Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2015Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1236000
CY2015Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7766000
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2753000
CY2015Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1422000
CY2015Q1 us-gaap Assets
Assets
133825000
CY2015Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
21615000
CY2015Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q2 dei Trading Symbol
TradingSymbol
AMSC
CY2015Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000880807
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13953647
CY2015Q2 us-gaap Cost Of Revenue
CostOfRevenue
20503000
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
12087000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3162000
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3120000
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7535000
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7938000
CY2014Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
1179000
CY2014Q2 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
39000
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
24363000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12667000
CY2014Q2 amsc Gain Loss In Change Of Fair Value Of Derivative Instruments And Warrants
GainLossInChangeOfFairValueOfDerivativeInstrumentsAndWarrants
-35000
CY2015Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-318000
CY2014Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-535000
CY2015Q1 amsc Noncurrent Portion Of Unamortized Debt Discount
NoncurrentPortionOfUnamortizedDebtDiscount
290000
CY2015Q1 amsc Current Portion Of Unamortized Debt Discount
CurrentPortionOfUnamortizedDebtDiscount
244000
CY2015Q2 amsc Noncurrent Portion Of Unamortized Debt Discount
NoncurrentPortionOfUnamortizedDebtDiscount
233000
CY2015Q2 amsc Current Portion Of Unamortized Debt Discount
CurrentPortionOfUnamortizedDebtDiscount
190000
CY2015Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
741000
CY2015Q2 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
39000
CY2015Q2 us-gaap Costs And Expenses
CostsAndExpenses
31980000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8257000
CY2015Q2 amsc Gain Loss In Change Of Fair Value Of Derivative Instruments And Warrants
GainLossInChangeOfFairValueOfDerivativeInstrumentsAndWarrants
800000
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-772000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-9121000
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12111000
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12111000
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
430000
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
430000
CY2015Q2 us-gaap Inventory Write Down
InventoryWriteDown
602000
CY2014Q2 us-gaap Inventory Write Down
InventoryWriteDown
649000
CY2015Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-356000
CY2015Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
111000
CY2015Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1414000
CY2015Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2968000
CY2015Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-271000
CY2015Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
197000
CY2015Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7000
CY2015Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
4000
CY2015Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-130000
CY2015Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-64000
CY2015Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
98000
CY2015Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-152000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8547000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-13389000
CY2015Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
329000
CY2014Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
34000
CY2015Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
107000
CY2014Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1431000
CY2015Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
18071000
CY2014Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6490000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43114000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36624000
CY2015Q2 us-gaap Interest Paid
InterestPaid
220000
CY2014Q2 us-gaap Interest Paid
InterestPaid
368000
CY2015Q2 us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Nature of the Business and Operations and Liquidity </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Nature of the Business and Operations </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">American Superconductor Corporation (&#8220;AMSC&#8221; or the &#8220;Company&#8221;) was founded on April&#160;9, 1987. The Company is a leading provider of megawatt-scale solutions that lower the cost of wind power and enhance the performance of the power grid. In the wind power market, the Company enables manufacturers to field wind turbines through its advanced engineering, support services and power electronics products. In the power grid market, the Company enables electric utilities and renewable energy project developers to connect, transmit and distribute power through its transmission planning services and power electronics and superconductor-based products. The Company&#8217;s wind and power grid products and services provide exceptional reliability, security, efficiency and affordability to its customers. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These unaudited condensed consolidated financial statements of the Company have been prepared on a going concern basis in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;) and the Securities and Exchange Commission&#8217;s (&#8220;SEC&#8221;) instructions to Form 10-Q. The going concern basis of presentation assumes that the Company will continue operations and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to those instructions. The year-end condensed balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The unaudited condensed consolidated financial statements, in the opinion of management, reflect all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the results for the interim periods ended June 30, 2015 and 2014 and the financial position at June 30, 2015. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 24, 2015, the Company effected a 1-for-10 reverse stock split of its common stock. Trading of the Company&#8217;s common stock reflected the reverse stock split beginning on March 25, 2015. Unless otherwise indicated, all historical references to shares of common stock, shares of restricted stock, restricted units, shares underlying options, warrants or calculations that use common stock for per share financial reporting have been adjusted for comparative purposes to reflect the impact of the 1-for-10 reverse stock split as if it had occurred at the beginning of the earliest period presented.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Liquidity </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has experienced recurring operating losses and as of June 30, 2015, the Company had an accumulated deficit of $914.2 million. In addition, the Company has experienced recurring negative operating cash flows.&nbsp;&nbsp;At June 30, 2015, the Company had cash and cash equivalents of $38.6 million. Cash used in operations for the three months ended June 30, 2015 was $3.0 million.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From April 1, 2011 through the date of this filing, the Company has reduced its global workforce substantially.&nbsp;&nbsp;The Company is currently in the process of consolidating certain business operations to reduce facility costs.&nbsp;&nbsp;As of June 30, 2015, the Company had a global workforce of 308 persons.&nbsp;&nbsp;The Company plans to closely monitor its expenses and if required, expects to further reduce operating costs and capital spending to enhance liquidity. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over the last several years, the Company has entered into several debt and equity financing arrangements in order to enhance liquidity.&nbsp;&nbsp;Since April 1, 2012, the Company has generated aggregate cash flows from financing activities of $74.0 million.&nbsp;&nbsp;This amount includes proceeds from an April 2015 equity offering, which generated net proceeds of approximately $22.3 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.&nbsp;&nbsp;See Note 10, &#8220;Debt&#8221;, and Note 12 &#8220;Stockholders Equity&#8221; for further discussion of these financing arrangements. The Company believes that it is in compliance with the covenants and restrictions included in the agreements governing its debt arrangements as of June 30, 2015.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company believes it has sufficient liquidity to fund its operations, capital expenditures and scheduled cash payments under its debt obligations for the next twelve months. The Company&#8217;s liquidity is highly dependent on, its ability to increase revenues, its ability to control its operating costs, its ability to maintain compliance with the covenants and restrictions on its debt obligations (or obtain waivers from its lender in the event of non-compliance), and its ability to raise additional capital, if necessary. There can be no assurance that the Company will be able to continue to raise additional capital from other sources or execute on any other means of improving liquidity described above. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company no longer believes its investments in Tres Amigas, LLC, a Delaware limited liability company (&#8220;Tres Amigas&#8221;) or Blade Dynamics Ltd. (&#8220;Blade Dynamics&#8221;) are recoverable.&nbsp;&nbsp;The Company fully impaired its remaining investments in both, recording a charge of $0.7 million during the three months ended June 30, 2015 for Tres Amigas and $3.5 million in the three months ended September 30, 2014 for Blade Dynamics. (See Note 14, &#8220;Minority Investments&#8221;, for further information about such investments). </p></div>
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
574000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
128000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-13517000
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.74
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.74
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7769000
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7769000
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-101000
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-101000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8691000
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13618000
CY2015Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2028000
CY2014Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2475000
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1128000
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1581000
CY2015Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
746000
CY2015Q2 amsc Writeoff Prepaid Taxes
WriteoffPrepaidTaxes
820000
CY2014Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-202000
CY2014Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
190000
CY2015Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-553000
CY2014Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-49000
CY2014Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2741000
CY2014Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-623000
CY2014Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-441000
CY2015Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3024000
CY2014Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1344000
CY2015Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1087000
CY2014Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5851000
CY2015Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3035000
CY2014Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5506000
CY2014Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
287000
CY2014Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000
CY2014Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-108000
CY2014Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
93000
CY2014Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-267000
CY2014Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
368000
CY2014Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1442000
CY2015Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
22281000
CY2014Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1177000
CY2015Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
21183000
CY2014Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-633000
CY2015Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-13000
CY2014Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-84000
CY2015Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2015Q2 dei Entity Number Of Employees
EntityNumberOfEmployees
308
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
74000000
CY2015Q2 amsc Weighted Average Shares Of Common Stock Outstanding
WeightedAverageSharesOfCommonStockOutstanding
12312000
CY2015Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22300000
CY2015Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1128000
CY2014Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1581000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.855
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1600000
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000
CY2014Q2 amsc Weighted Average Shares Of Common Stock Outstanding
WeightedAverageSharesOfCommonStockOutstanding
7962000
CY2015Q2 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
201000
CY2014Q2 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
193000
CY2015Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
26010000
CY2015Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
12519000
CY2015Q2 us-gaap Billed Contract Receivables
BilledContractReceivables
6601000
CY2015Q1 us-gaap Billed Contract Receivables
BilledContractReceivables
8946000
CY2015Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
1944000
CY2015Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
987000
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
54000
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
54000
CY2015Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
8018000
CY2015Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
9411000
CY2015Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1092000
CY2015Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2117000
CY2015Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6286000
CY2015Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7487000
CY2015Q2 us-gaap Inventory For Long Term Contracts Or Programs
InventoryForLongTermContractsOrPrograms
1684000
CY2015Q1 us-gaap Inventory For Long Term Contracts Or Programs
InventoryForLongTermContractsOrPrograms
1581000
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6613000
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7062000
CY2015Q2 amsc Accrued Inventories In Transit
AccruedInventoriesInTransit
964000
CY2015Q1 amsc Accrued Inventories In Transit
AccruedInventoriesInTransit
1127000
CY2015Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2969000
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2695000
CY2015Q2 amsc Accrued Outside Services
AccruedOutsideServices
684000
CY2015Q1 amsc Accrued Outside Services
AccruedOutsideServices
582000
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3545000
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5937000
CY2015Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
526000
CY2015Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
278000
CY2015Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3344000
CY2015Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3934000
CY2014Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3207000
CY2015Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-5000
CY2014Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-72000
CY2015Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
585000
CY2014Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
280000
CY2014Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2855000
CY2014Q2 us-gaap Severance Costs1
SeveranceCosts1
1200000
CY2015Q1 us-gaap Restructuring Reserve
RestructuringReserve
180000
CY2015Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
162000
CY2015Q2 us-gaap Restructuring Reserve
RestructuringReserve
18000
CY2014Q1 us-gaap Restructuring Reserve
RestructuringReserve
844000
CY2014Q2 us-gaap Restructuring Charges
RestructuringCharges
1179000
CY2014Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
1078000
CY2014Q2 us-gaap Restructuring Reserve
RestructuringReserve
945000
CY2015Q2 us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
As part of the Hercules Second Amendment, this Minimum Threshold was amended to be the lower of $5.0 million or the aggregate outstanding principal balance of the Term Loans. As a result of the Company’s April 2015 equity offering, the Minimum Threshold was reduced to the lesser of $2.0 million or the aggregate outstanding principal balance of the Term Loans.
CY2015Q2 us-gaap Interest Expense
InterestExpense
300000
CY2014Q2 us-gaap Interest Expense
InterestExpense
500000
CY2015Q2 amsc Non Cash Interest Expense Amortization Of Debt Discount
NonCashInterestExpenseAmortizationOfDebtDiscount
100000
CY2014Q2 amsc Non Cash Interest Expense Amortization Of Debt Discount
NonCashInterestExpenseAmortizationOfDebtDiscount
200000
CY2012Q2 invest Investment Warrants Expiration Date
InvestmentWarrantsExpirationDate
2017-12-05
CY2013Q4 invest Investment Warrants Expiration Date
InvestmentWarrantsExpirationDate
2019-05-15
CY2014Q4 us-gaap Common Unit Issued
CommonUnitIssued
909090
CY2014Q4 amsc Warrants To Purchase One Share Of Common Stock
WarrantsToPurchaseOneShareOfCommonStock
0.9
CY2014Q4 amsc Number Of Warrants Issued To Purchase Common Stock
NumberOfWarrantsIssuedToPurchaseCommonStock
818181
CY2014Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
11.00
CY2015Q2 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
9.41
CY2014Q4 invest Investment Warrants Expiration Date
InvestmentWarrantsExpirationDate
2019-11-13
CY2014Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9100000
CY2015Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2015Q2 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
700000
CY2014Q2 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
1200000

Files In Submission

Name View Source Status
0001564590-15-006142-index-headers.html Edgar Link pending
0001564590-15-006142-index.html Edgar Link pending
0001564590-15-006142.txt Edgar Link pending
0001564590-15-006142-xbrl.zip Edgar Link pending
amsc-10q_20150630.htm Edgar Link pending
amsc-20150630.xml Edgar Link completed
amsc-20150630.xsd Edgar Link pending
amsc-20150630_cal.xml Edgar Link unprocessable
amsc-20150630_def.xml Edgar Link unprocessable
amsc-20150630_lab.xml Edgar Link unprocessable
amsc-20150630_pre.xml Edgar Link unprocessable
amsc-ex101_232.htm Edgar Link pending
amsc-ex311_201506308.htm Edgar Link pending
amsc-ex312_201506306.htm Edgar Link pending
amsc-ex321_2015063010.htm Edgar Link pending
amsc-ex322_201506307.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending